IRF5 and rheumatoid arthritis: They also demonstrated the differential antibody responses to BOLF1, MAP_4027 and IRF5 peptides could be used as diagnostic biomarkers among connective tissue diseases (rheumatoid arthritis, RA; systemic lupus erythematosus, SLE) [8].